Development of drug-loaded chitosan–vanillin nanoparticles and its cytotoxicity against HT-29 cells

References

• Ajit PR, Namdev BS, Sangamesh AP, Tejraj MA. (2007). Novel interpenetrating polymer network microspheres of chitosan and methycellulose for controlled release of theophylline. Carbohydr Polym 69:678–87
   Web of Science ®Google Scholar
• Ali F, Elina EG, Mahnaz A, et al. (2014). Preparation and characterization of self-assembled chitosan nanoparticles for the sustained delivery of streptokinase: an in vivo study. Drug Deliv 19:593–7
   Google Scholar
• Almalik A, Donno R, Christopher J, et al. (2013). Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation. J Control Release 172:1142–50
   PubMed Web of Science ®Google Scholar
• Baek SH, Kim B, Suh KD (2008). Chitosan particles/multiwall carbon nanotube composites by electrostatic interactions. Coll Surfaces A Physicochem Eng Aspects 316:292–6
   Web of Science ®Google Scholar
• Bharmoria P, Singh T, Kumar A. (2013). Complexation of chitosan with surfactant like ionic liquids: molecular interactions and preparation of chitosan nanoparticles. J Coll Interface Sci 407:361–9
   PubMed Web of Science ®Google Scholar
• Campos AM, Diebold Y, Carvalho ELS, et al. (2004). Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 21:803–10
   PubMed Web of Science ®Google Scholar
• Fürst W, Banerjee A. (2005). Release of glutaraldehyde from an albumin-glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity. Ann Thorac Surg 79:1522–8
   PubMed Web of Science ®Google Scholar
• Gu FX, Karnik R, Wang AZ, et al. (2007). Targeted nanoparticles for cancer therapy. Nano Today 2:14–21
   Web of Science ®Google Scholar
• Gupta KC, Jabrail FH. (2006). Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman. Carbohydr Res 341:744–56
   PubMed Web of Science ®Google Scholar
• Ho K, Yazan LS, Ismail N, Ismail M. (2011). Toxicology study of vanillin on rats via oral and intra-peritoneal administration. Food Chem Toxicol 49:25–30
   PubMed Web of Science ®Google Scholar
• Hongyan Z, Fei L, Jing G, et al. (2011). Folate-modified chitosan micelles with enhanced tumor targeting evaluated by near infrared imaging system. Carbohydr Polym 86:1118–29
   Web of Science ®Google Scholar
• Hua DB, Jiang JL, Kuang LJ, et al. (2011). Smart chitosan-based stimuli-responsive nanocarriers for the controlled delivery of hydrophobic pharmaceuticals. Macromolecules 44:1298–302
   Web of Science ®Google Scholar
• Jana S, Maji N, Nayak AK, et al. (2013). Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery. Carbohydr Polym 98:870–6
   PubMed Web of Science ®Google Scholar
• Li PW, Wang YC, Peng Z, et al. (2011a). Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends. Carbohydr Polym 85:698–704
   Web of Science ®Google Scholar
• Li PW, Wang YC, Zeng FB, et al. (2011b). Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohydr Res 346:801–6
   PubMed Web of Science ®Google Scholar
• Li QX, Song BZ, Yang ZQ, Fan HL. (2006). Preparation and characterization of chitosan microcapsules crosslinked by vanillin. Chin J Process Eng 6:608–13
   Google Scholar
• Makni M, Chtourou Y, Fetoui H, et al. (2011). Evaluation of the antioxidant, anti-inflammatory and hepatoprotective properties of vanillin in carbon tetrachloride-treated rats. Eur J Pharmacol 668:133–9
   PubMed Web of Science ®Google Scholar
• Mao HQ, Roy K, Troung-Le VL, et al. (2001). Chitosan DNA nanoparticles as gene delivery carriers: synthesis, characterization and transfection efficiency. J Control Release 70:399–421
   PubMed Web of Science ®Google Scholar
• Pan Y, Li Y, Zhao H, et al. (2002). Chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249:139–47
   PubMed Web of Science ®Google Scholar
• Peng HL, Xiong H, Li JH, et al. (2010). Vanillin cross-linked chitosan microspheres for controlled release of resveratrol. Food Chem 121:23–8
   Web of Science ®Google Scholar
• Prabaharan M, Borges JP, Godinho MH, Mano JF. (2006). Liquid crystalline behaviour of chitosan in formic, acetic, monochloroacetic acid solutions. Mater Sci Forum 514–516:1010–4
   Google Scholar
• Pramila C, Brahmeshwar M. (2014). Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. Carbohydr Polym 101:1101–8
   PubMed Web of Science ®Google Scholar
• Rathna GVN. (2008). Gelatin hydrogels: enhanced biocompatibility, drug release and cell viability. J Mater Sci Mater Med 19:2351–8
   PubMed Web of Science ®Google Scholar
• Rubert ND, Lorena T, Montserrat M, et al. (2013). In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles. Biomaterials 34:2758–72
   PubMed Web of Science ®Google Scholar
• Sang NV, Hiep DM, Zung NA. (2013). Study on chitosan nanoparticles on biophysical characteristics and growth of Robusta coffee in green house. Biocatal Agric Biotechnol 2:289–94
   Google Scholar
• Tai A, Sawano T, Yazama F, Ito H. (2011). Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays. Biochim Biophys Acta 1810:170–7
   PubMed Web of Science ®Google Scholar
• Wang G, Li PW, Peng Z, et al. (2011). Formulation of vanillin cross-linked chitosan nanoparticles and its characterization. Adv Mater Res 335–336:474–7
   Google Scholar
• Zhang ZJ. (2004). Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 75:1659–99
   PubMed Web of Science ®Google Scholar
• Zheng AP, Liu HX, Yuan L, et al. (2011). Comprehensive studies on the interactions between chitosan nanoparticles and some live cells. J Nanopart Res 13:4765–76
   Web of Science ®Google Scholar